Editorial Comment.
暂无分享,去创建一个
[1] A. Lopez‐Beltran,et al. New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen , 2018, Front. Oncol..
[2] T. H. van der Kwast,et al. Grading of prostate cancer: a work in progress , 2018, Histopathology.
[3] A. Evans,et al. Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set , 2018, Histopathology.
[4] A. Lopez‐Beltran,et al. Prostate cancer grading in 2018: limitations, implementations, cribriform morphology, and biological markers , 2018, The International journal of biological markers.
[5] R. Montironi,et al. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma , 2018, Expert review of anticancer therapy.
[6] H. Miyamoto,et al. Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer , 2018, Translational andrology and urology.
[7] T. H. van der Kwast,et al. Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy. , 2012, European journal of cancer.
[8] M. Rubin,et al. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma. , 2007, Archives of pathology & laboratory medicine.